Predictors of Cognitive Decline in Normal Aging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00094939|
Recruitment Status : Unknown
Verified September 2009 by National Institute on Aging (NIA).
Recruitment status was: Recruiting
First Posted : October 29, 2004
Last Update Posted : December 14, 2009
|Condition or disease|
|Alzheimer Disease Dementia|
Studies of normal aging and mild cognitive impairment (MCI) show that loss of neurons and reduction in size of the hippocampal part of the brain predict a person's conversion from MCI to Alzheimer's disease (AD). Increases in tangle-related abnormal tau proteins, specifically P-tau231, also appear to be related.
This study will collect neuropsychological data, magnetic resonance imaging (MRI), and cerebrospinal fluid (CSF) from volunteer participants to measure the relationship between changes in brain volume, CSF levels, and memory performance.
From the data researchers hope to develop an early diagnostic test for AD.
The study will include 170 participants between the ages of 60 and 80 years, some normal, some with MCI, some with mild AD, and some with frontotemporal dementia. After initial screening of volunteers, the researchers will give participants a complete baseline exam and 24-month follow-up exams over a period of five years.
|Study Type :||Observational|
|Estimated Enrollment :||170 participants|
|Official Title:||Predictors of Cognitive Decline in Normal Aging|
|Study Start Date :||September 2003|
|Study Completion Date :||August 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00094939
|Contact: Kenneth E. Richemail@example.com|
|United States, New York|
|Center for Brain Health, Silberstein Institute, New York University School of Medicine||Recruiting|
|New York City, New York, United States, 10016|
|Contact: Kenneth E. Rich 212-263-7563 firstname.lastname@example.org|
|Principal Investigator:||Mony J. de Leon, Ed.D.||Center for Brain Health, Silberstein Institute|